| NCT ID | NCT07781306 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cancer Research Antwerp |
| Condition | Liver Metastases |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-09-08 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2020-09-08 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a non-interventional, observational study with an optional interventional biobanking activity. Liver metastases of patients undergoing partial hepatectomy will be sampled completely while respecting the orientation used for medical imaging, in order to correlate the histopathological growth patterns in a 3D-map with the imaging characteristics. The full pathological sampling will only use remnant tissue.
Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years old. 2. Patients with liver metastatic colorectal or breast carcinoma undergoing a surgical excision of the liver metastases 3. Therapy-naive patients as well as patients with neo-adjuvant therapy are eligible for inclusion 4. Willingness of the patient to participate in this study demonstrated by signed written informed consent Exclusion Criteria: 1. Patients without MRI or CT of the liver prior to surgery 2. Time interval between medical imaging, CT and/or MRI is more than 12 weeks (nb: time interval is preferably less than 4 weeks but this is not an exclusion criterium) 3. Prior radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) on the liver metastasis that would be operated
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07781306 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Liver Metastases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07781306 currently recruiting?
Yes, NCT07781306 is actively recruiting participants. Contact the research team at peter.vermeulen@zas.be for enrollment information.
Where is the NCT07781306 trial being conducted?
This trial is being conducted at Wilrijk, Belgium.
Who is sponsoring the NCT07781306 clinical trial?
NCT07781306 is sponsored by Cancer Research Antwerp. The trial plans to enroll 50 participants.